Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Submitted by
admin
on December 7, 2017 - 9:18am
Source:
Xconomy
News Tags:
SAGE Therapeutics
major depressive disorder
SAGE-217
Headline:
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Do Not Allow Advertisers to Use My Personal information
